Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-16-034627

Director sold 22,086 shares at $11.18 ($247,008)

  • Director disposed of 400,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Canaan IX L.P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-11-29 Sale : show line 1 in the form −22,086 $11.18 $247,008 3,644,381 I
2016-11-30 Other disposition : show line 2 in the form −400,000 3,244,381 I
Open-market sales · 22,086 sh · avg $11.18 · $247,008
Loading xslF345X03/doc4.xml…